CAPLIPOINT2,792.00

Caplin Point Laboratories Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAJANTPHARMERISGLANDBLUEJETCONCORDBIOACUTAASEMCUREGRANULESMcap ₹21,219 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,694.11,937.52,187.22,287.3
Other Income66.996.4115.5126.0
Total Income1,761.02,033.92,302.72,413.3
Expenses
+ Cost of Materials Consumed239.8248.5357.2390.8
+ Purchases of Stock-in-Trade558.9575.7572.2655.1
+ Changes in Inventories-74.6-53.3-63.7-130.2
+ Employee Benefit Expense143.6177.7199.2203.8
+ Finance Costs0.80.60.90.9
+ Depreciation & Amortisation53.466.072.878.1
+ Other Expenses274.9342.0361.5371.4
Total Expenses1,196.91,357.11,500.01,569.7
EBITDA551.4646.9760.9796.6
EBIT498.0581.0688.1718.5
Profit
PBT before Exceptional Items564.2676.8802.8843.6
+ Exceptional Items0.30.00.00.0
Pretax Income564.4676.8802.8843.6
+ Current Tax101.6125.3146.3159.4
+ Deferred Tax1.510.46.86.1
Tax Expense103.0135.7153.1165.5
+ Share of Associates & JVs0.0-0.00.0-0.0
Net Income461.4541.1649.7678.1
+ Net Income — Continuing Ops461.4541.1649.7678.1
+ Other Comprehensive Income11.527.1141.6139.4
Total Comprehensive Income472.9568.2791.4817.5
Net Income to Common457.1563.4641.2665.4
Minority Interest4.34.88.512.7
Per Share
Basic EPS60.1970.5784.3687.53
Diluted EPS59.9070.2584.1187.28
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs0.00.0-0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income27.1141.6139.4
+ Items NOT to be Reclassified to P&L-0.00.10.2
+ Tax on Items NOT to be Reclassified0.00.00.3
+ Tax on Items NOT to be Reclassified — alt tag-0.0
+ Items to be Reclassified to P&L11.527.0141.4139.2
Comprehensive Income — Owners of Parent468.5782.9804.8
Comprehensive Income — Non-controlling Interests4.38.512.7
Per Share — as-filed variants
Basic EPS — Continuing Operations60.1970.5784.3687.53
Diluted EPS — Continuing Operations59.9070.2584.1187.28
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit969.91,166.61,321.51,371.7
Gross Margin %57.2560.2160.4259.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)564.2676.8802.8843.6
− Exceptional Items (reconciliation)0.30.00.00.0
Net Income Adj (tax-effected)461.2541.1649.7678.1
EPS Adj60.1670.5784.3687.53
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital15.215.215.215.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.